Baidu
map

重磅:2016年NCCN全新发布指南 TOP30

2016-12-22 MedSci NCCN官网

2016年美国国家综合癌症网络(NCCN)发布了一系列指南,梅斯医学小编针对常见肿瘤和多发肿瘤对NCCN在2016年最新发布的指南进行了整理,与大家分享。 1 2017 NCCN临床实践指南:子宫肿瘤(2017.V1)2016年11月,美国国家综合癌症网络(NCCN)发布了子宫肿瘤指南2017年第1版。 2 2017 NCCN临床实践指南:直肠癌(2017.V1)2016年

2016年美国国家综合癌症网络(NCCN)发布了一系列指南,梅斯医学小编针对常见肿瘤和多发肿瘤对NCCN在2016年最新发布的指南进行了整理,与大家分享。 

1 2017 NCCN临床实践指南:子宫肿瘤(2017.V1)

2016年11月,美国国家综合癌症网络(NCCN)发布了子宫肿瘤指南2017年第1版。 

2 2017 NCCN临床实践指南:直肠癌(2017.V1)

2016年11月23日,NCCN发布了直肠癌临床实践指南2017年第1版。 

3 2017 NCCN临床实践指南:小细胞肺癌(2017.V2)

2016年9月,美国国家综合癌症网络(NCCN)发布了小细胞肺癌指南2016年第2版。 

4 2017 NCCN临床实践指南:肾癌(2017.V2)

2016年10月,美国国家综合癌症网络(NCCN)发布了肾癌指南2017年第2版。 

5 2017 NCCN临床实践指南:慢性髓性白血病(2017.V1)

2016年11月,美国国家综合癌症网络(NCCN)发布了慢性髓性白血病指南2017年第1版。 

6 2017 NCCN临床实践指南:慢性淋巴细胞白血病/小淋巴细胞淋巴瘤(2017.V1)

2016年9月,美国国家综合癌症网络(NCCN)发布了慢性淋巴细胞白血病/小淋巴细胞淋巴瘤指南2017年第一版,该指南的前一版来自2016年第3版非霍奇金淋巴瘤指南的部分。 

7 2017 NCCN临床实践指南:结肠癌(2017.V1)

2016年11月23日,NCCN发布了结肠癌临床实践指南2017年第1版。 

8 2017 NCCN临床实践指南:黑色素瘤(2017.V1)

2016年11月,美国国家综合癌症网络(NCCN)发布了黑色素瘤指南2017年第1版。 

9 2017 NCCN临床实践指南:骨肿瘤(2017.V2)

2016年11月,美国国家综合癌症网络(NCCN)发布了骨肿瘤指南2017年第2版。 

10 2017 NCCN临床实践指南:宫颈癌(2017.V1)

2016年10月,美国国家综合癌症网络(NCCN)发布了宫颈癌指南2017年第1版。 

11 2017 NCCN临床实践指南:肺癌筛查(2017.V1)

2016年8月,美国国家综合癌症网络(NCCN)发布了肺癌筛查指南2017年第一版。 

12 2017 NCCN临床实践指南:非小细胞肺癌(2017.V3)

2016年11月16日,美国国家综合癌症网络(NCCN)发布了非小细胞肺癌指南2017年第3版。 

13 2016 NCCN临床实践指南:胃癌(2016.V3)

2016年8月,美国国家综合癌症网络(NCCN)发布了胃癌指南2016年第3版。 

14 2016 NCCN临床实践指南:中枢神经系统肿瘤(2016.V1)

2016年7月,美国国家综合癌症网络(NCCN)发布了中枢神经系统肿瘤指南2016年第1版。 

15 2016 NCCN临床实践指南:胰腺癌(2016.V2)

2016年8月,美国国家综合癌症网络(NCCN)发布了胰腺癌临床实践指南2016年第2版。 

16 2016 NCCN临床实践指南:食道癌和胃食管交界处癌(2016.V2)

2016年7月,美国国家综合癌症网络(NCCN)发布了食道癌和胃食管交界处癌指南2016年第2版。 

17 2016 NCCN临床实践指南:乳腺癌筛查和诊断(2016.V1)

2016年7月,美国国家综合癌症网络(NCCN)发布了乳腺癌筛查和诊断指南2016年第1版。 

18 2016 NCCN临床实践指南:乳腺癌(2016.V2)

2016年5月,美国国家综合癌症网络(NCCN)发布了乳腺癌实践指南2016年第2版。 

19 2016 NCCN临床实践指南:前列腺癌早期检测(2016.V2)

2016年4月,美国国家综合癌症网络(NCCN)发布了前列腺癌早期检测指南2016年第2版。 

20.2017 NCCN临床实践指南:前列腺癌(2017.V1)

2016年12月,美国国家综合癌症网络(NCCN)发布了前列腺癌指南2017年第一版。 

21 2016 NCCN临床实践指南:膀胱癌(2016.V2)

2016年6月,美国国家综合癌症网络(NCCN)发布了膀胱癌指南2016年第2版。 

22 2016 NCCN临床实践指南:卵巢癌包括输卵管癌和原发性腹膜癌(2016.V1)

2016年6月,美国国家综合癌症网络(NCCN)发布了卵巢癌包括输卵管癌和原发性腹膜癌指南2016第1版。 

23 2016 NCCN临床实践指南:结直肠癌筛查(2016.V2)

2016年10月,美国国家综合癌症网络(NCCN)发布了结直肠癌筛查指南2016年第2版。 

24 2016 NCCN临床实践指南:急性髓性白血病(2016.V2)

2016年6月,美国国家综合癌症网络(NCCN)发布了急性髓性白血病指南2016第2版。 

25 2016 NCCN临床实践指南:急性淋巴细胞白血病(2016.V2)

2016年9月,美国国家综合癌症网络(NCCN)发布了急性淋巴细胞白血病2016年第2版。 

26 2016 NCCN临床实践指南:霍奇金淋巴瘤(2016.V3)

2016年6月,美国国家综合癌症网络(NCCN)发布了霍奇金淋巴瘤指南2016年第3版。 

27 2016 NCCN临床实践指南:肝胆肿瘤(2016.V2)

2016年6月,美国国家综合癌症网络(NCCN)发布了肝胆肿瘤2016年第2版。 

28 2016 NCCN临床实践指南:非霍奇金淋巴瘤(2016.V3)

2016年5月,美国国家综合癌症网络(NCCN)发布了非霍奇金淋巴瘤指南2016年第三版。 

29.2017 NCCN临床实践指南:T细胞淋巴瘤(2017.V1)

2016年12月,美国国家综合癌症网络(NCCN)发布了T细胞淋巴瘤指南2017年第1版。 

30.2017 NCCN临床实践指南:毛细胞白血病(2017.V1)

2016年12月,美国国家综合癌症网络(NCCN)发布了毛细胞白血病指南2017年第一版。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (7)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1814749, encodeId=22ed1814e49e4, content=<a href='/topic/show?id=bd3d960016d' target=_blank style='color:#2F92EE;'>#重磅:2016年#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96001, encryptionId=bd3d960016d, topicName=重磅:2016年)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2b9b368, createdName=qingrejiedu, createdTime=Sun Sep 24 11:43:00 CST 2017, time=2017-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=165893, encodeId=272216589311, content=怎么看不到指南, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NdicLmdJEK9VoiaDianY6fzHNN9iaGv80m39pMHU3eSnNN0kn1o0rdQ7Bz2f03Qibcf1ia7rKvxIt4UVlErF2d4gCmDC5/0, createdBy=98e31740255, createdName=cqykthl, createdTime=Mon Dec 26 23:27:23 CST 2016, time=2016-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1319825, encodeId=ba5b1319825de, content=<a href='/topic/show?id=c806125e30b' target=_blank style='color:#2F92EE;'>#NCCN#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12573, encryptionId=c806125e30b, topicName=NCCN)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e572480, createdName=旅苦化文_208, createdTime=Sat Dec 24 02:43:00 CST 2016, time=2016-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1548972, encodeId=831415489e2c9, content=<a href='/topic/show?id=f7879600061' target=_blank style='color:#2F92EE;'>#重磅#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96000, encryptionId=f7879600061, topicName=重磅)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3acc14121561, createdName=xxxx1054, createdTime=Sat Dec 24 02:43:00 CST 2016, time=2016-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1602773, encodeId=ddec1602e73de, content=<a href='/topic/show?id=26141e6543f' target=_blank style='color:#2F92EE;'>#TOP30#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17654, encryptionId=26141e6543f, topicName=TOP30)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9b0318920751, createdName=ailian1208, createdTime=Sat Dec 24 02:43:00 CST 2016, time=2016-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=164915, encodeId=0b9316491533, content=可见知识更新的必要性, beContent=null, objectType=article, channel=null, level=null, likeNumber=120, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/11/19/9bc45f4ae162bd654210831f4e7ea3d0.jpg, createdBy=bbf11609910, createdName=杨帆7792, createdTime=Thu Dec 22 16:31:56 CST 2016, time=2016-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=164873, encodeId=306a1648e326, content=很好,不错的资料,值得收藏,给自己学习探究提供了方便。, beContent=null, objectType=article, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zMoyicyo6ia9f4IuLQAwZoxD6Hx4ibd5CMcOCYhStY6oDibbKK6O2X8iaicldO5ib8j1iapOIobIKCGiczU2A/0, createdBy=56251941490, createdName=虈亣靌, createdTime=Thu Dec 22 13:24:48 CST 2016, time=2016-12-22, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1814749, encodeId=22ed1814e49e4, content=<a href='/topic/show?id=bd3d960016d' target=_blank style='color:#2F92EE;'>#重磅:2016年#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96001, encryptionId=bd3d960016d, topicName=重磅:2016年)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2b9b368, createdName=qingrejiedu, createdTime=Sun Sep 24 11:43:00 CST 2017, time=2017-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=165893, encodeId=272216589311, content=怎么看不到指南, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NdicLmdJEK9VoiaDianY6fzHNN9iaGv80m39pMHU3eSnNN0kn1o0rdQ7Bz2f03Qibcf1ia7rKvxIt4UVlErF2d4gCmDC5/0, createdBy=98e31740255, createdName=cqykthl, createdTime=Mon Dec 26 23:27:23 CST 2016, time=2016-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1319825, encodeId=ba5b1319825de, content=<a href='/topic/show?id=c806125e30b' target=_blank style='color:#2F92EE;'>#NCCN#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12573, encryptionId=c806125e30b, topicName=NCCN)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e572480, createdName=旅苦化文_208, createdTime=Sat Dec 24 02:43:00 CST 2016, time=2016-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1548972, encodeId=831415489e2c9, content=<a href='/topic/show?id=f7879600061' target=_blank style='color:#2F92EE;'>#重磅#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96000, encryptionId=f7879600061, topicName=重磅)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3acc14121561, createdName=xxxx1054, createdTime=Sat Dec 24 02:43:00 CST 2016, time=2016-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1602773, encodeId=ddec1602e73de, content=<a href='/topic/show?id=26141e6543f' target=_blank style='color:#2F92EE;'>#TOP30#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17654, encryptionId=26141e6543f, topicName=TOP30)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9b0318920751, createdName=ailian1208, createdTime=Sat Dec 24 02:43:00 CST 2016, time=2016-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=164915, encodeId=0b9316491533, content=可见知识更新的必要性, beContent=null, objectType=article, channel=null, level=null, likeNumber=120, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/11/19/9bc45f4ae162bd654210831f4e7ea3d0.jpg, createdBy=bbf11609910, createdName=杨帆7792, createdTime=Thu Dec 22 16:31:56 CST 2016, time=2016-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=164873, encodeId=306a1648e326, content=很好,不错的资料,值得收藏,给自己学习探究提供了方便。, beContent=null, objectType=article, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zMoyicyo6ia9f4IuLQAwZoxD6Hx4ibd5CMcOCYhStY6oDibbKK6O2X8iaicldO5ib8j1iapOIobIKCGiczU2A/0, createdBy=56251941490, createdName=虈亣靌, createdTime=Thu Dec 22 13:24:48 CST 2016, time=2016-12-22, status=1, ipAttribution=)]
    2016-12-26 cqykthl

    怎么看不到指南

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1814749, encodeId=22ed1814e49e4, content=<a href='/topic/show?id=bd3d960016d' target=_blank style='color:#2F92EE;'>#重磅:2016年#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96001, encryptionId=bd3d960016d, topicName=重磅:2016年)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2b9b368, createdName=qingrejiedu, createdTime=Sun Sep 24 11:43:00 CST 2017, time=2017-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=165893, encodeId=272216589311, content=怎么看不到指南, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NdicLmdJEK9VoiaDianY6fzHNN9iaGv80m39pMHU3eSnNN0kn1o0rdQ7Bz2f03Qibcf1ia7rKvxIt4UVlErF2d4gCmDC5/0, createdBy=98e31740255, createdName=cqykthl, createdTime=Mon Dec 26 23:27:23 CST 2016, time=2016-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1319825, encodeId=ba5b1319825de, content=<a href='/topic/show?id=c806125e30b' target=_blank style='color:#2F92EE;'>#NCCN#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12573, encryptionId=c806125e30b, topicName=NCCN)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e572480, createdName=旅苦化文_208, createdTime=Sat Dec 24 02:43:00 CST 2016, time=2016-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1548972, encodeId=831415489e2c9, content=<a href='/topic/show?id=f7879600061' target=_blank style='color:#2F92EE;'>#重磅#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96000, encryptionId=f7879600061, topicName=重磅)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3acc14121561, createdName=xxxx1054, createdTime=Sat Dec 24 02:43:00 CST 2016, time=2016-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1602773, encodeId=ddec1602e73de, content=<a href='/topic/show?id=26141e6543f' target=_blank style='color:#2F92EE;'>#TOP30#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17654, encryptionId=26141e6543f, topicName=TOP30)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9b0318920751, createdName=ailian1208, createdTime=Sat Dec 24 02:43:00 CST 2016, time=2016-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=164915, encodeId=0b9316491533, content=可见知识更新的必要性, beContent=null, objectType=article, channel=null, level=null, likeNumber=120, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/11/19/9bc45f4ae162bd654210831f4e7ea3d0.jpg, createdBy=bbf11609910, createdName=杨帆7792, createdTime=Thu Dec 22 16:31:56 CST 2016, time=2016-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=164873, encodeId=306a1648e326, content=很好,不错的资料,值得收藏,给自己学习探究提供了方便。, beContent=null, objectType=article, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zMoyicyo6ia9f4IuLQAwZoxD6Hx4ibd5CMcOCYhStY6oDibbKK6O2X8iaicldO5ib8j1iapOIobIKCGiczU2A/0, createdBy=56251941490, createdName=虈亣靌, createdTime=Thu Dec 22 13:24:48 CST 2016, time=2016-12-22, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1814749, encodeId=22ed1814e49e4, content=<a href='/topic/show?id=bd3d960016d' target=_blank style='color:#2F92EE;'>#重磅:2016年#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96001, encryptionId=bd3d960016d, topicName=重磅:2016年)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2b9b368, createdName=qingrejiedu, createdTime=Sun Sep 24 11:43:00 CST 2017, time=2017-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=165893, encodeId=272216589311, content=怎么看不到指南, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NdicLmdJEK9VoiaDianY6fzHNN9iaGv80m39pMHU3eSnNN0kn1o0rdQ7Bz2f03Qibcf1ia7rKvxIt4UVlErF2d4gCmDC5/0, createdBy=98e31740255, createdName=cqykthl, createdTime=Mon Dec 26 23:27:23 CST 2016, time=2016-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1319825, encodeId=ba5b1319825de, content=<a href='/topic/show?id=c806125e30b' target=_blank style='color:#2F92EE;'>#NCCN#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12573, encryptionId=c806125e30b, topicName=NCCN)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e572480, createdName=旅苦化文_208, createdTime=Sat Dec 24 02:43:00 CST 2016, time=2016-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1548972, encodeId=831415489e2c9, content=<a href='/topic/show?id=f7879600061' target=_blank style='color:#2F92EE;'>#重磅#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96000, encryptionId=f7879600061, topicName=重磅)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3acc14121561, createdName=xxxx1054, createdTime=Sat Dec 24 02:43:00 CST 2016, time=2016-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1602773, encodeId=ddec1602e73de, content=<a href='/topic/show?id=26141e6543f' target=_blank style='color:#2F92EE;'>#TOP30#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17654, encryptionId=26141e6543f, topicName=TOP30)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9b0318920751, createdName=ailian1208, createdTime=Sat Dec 24 02:43:00 CST 2016, time=2016-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=164915, encodeId=0b9316491533, content=可见知识更新的必要性, beContent=null, objectType=article, channel=null, level=null, likeNumber=120, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/11/19/9bc45f4ae162bd654210831f4e7ea3d0.jpg, createdBy=bbf11609910, createdName=杨帆7792, createdTime=Thu Dec 22 16:31:56 CST 2016, time=2016-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=164873, encodeId=306a1648e326, content=很好,不错的资料,值得收藏,给自己学习探究提供了方便。, beContent=null, objectType=article, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zMoyicyo6ia9f4IuLQAwZoxD6Hx4ibd5CMcOCYhStY6oDibbKK6O2X8iaicldO5ib8j1iapOIobIKCGiczU2A/0, createdBy=56251941490, createdName=虈亣靌, createdTime=Thu Dec 22 13:24:48 CST 2016, time=2016-12-22, status=1, ipAttribution=)]
    2016-12-24 xxxx1054
  5. [GetPortalCommentsPageByObjectIdResponse(id=1814749, encodeId=22ed1814e49e4, content=<a href='/topic/show?id=bd3d960016d' target=_blank style='color:#2F92EE;'>#重磅:2016年#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96001, encryptionId=bd3d960016d, topicName=重磅:2016年)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2b9b368, createdName=qingrejiedu, createdTime=Sun Sep 24 11:43:00 CST 2017, time=2017-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=165893, encodeId=272216589311, content=怎么看不到指南, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NdicLmdJEK9VoiaDianY6fzHNN9iaGv80m39pMHU3eSnNN0kn1o0rdQ7Bz2f03Qibcf1ia7rKvxIt4UVlErF2d4gCmDC5/0, createdBy=98e31740255, createdName=cqykthl, createdTime=Mon Dec 26 23:27:23 CST 2016, time=2016-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1319825, encodeId=ba5b1319825de, content=<a href='/topic/show?id=c806125e30b' target=_blank style='color:#2F92EE;'>#NCCN#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12573, encryptionId=c806125e30b, topicName=NCCN)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e572480, createdName=旅苦化文_208, createdTime=Sat Dec 24 02:43:00 CST 2016, time=2016-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1548972, encodeId=831415489e2c9, content=<a href='/topic/show?id=f7879600061' target=_blank style='color:#2F92EE;'>#重磅#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96000, encryptionId=f7879600061, topicName=重磅)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3acc14121561, createdName=xxxx1054, createdTime=Sat Dec 24 02:43:00 CST 2016, time=2016-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1602773, encodeId=ddec1602e73de, content=<a href='/topic/show?id=26141e6543f' target=_blank style='color:#2F92EE;'>#TOP30#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17654, encryptionId=26141e6543f, topicName=TOP30)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9b0318920751, createdName=ailian1208, createdTime=Sat Dec 24 02:43:00 CST 2016, time=2016-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=164915, encodeId=0b9316491533, content=可见知识更新的必要性, beContent=null, objectType=article, channel=null, level=null, likeNumber=120, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/11/19/9bc45f4ae162bd654210831f4e7ea3d0.jpg, createdBy=bbf11609910, createdName=杨帆7792, createdTime=Thu Dec 22 16:31:56 CST 2016, time=2016-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=164873, encodeId=306a1648e326, content=很好,不错的资料,值得收藏,给自己学习探究提供了方便。, beContent=null, objectType=article, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zMoyicyo6ia9f4IuLQAwZoxD6Hx4ibd5CMcOCYhStY6oDibbKK6O2X8iaicldO5ib8j1iapOIobIKCGiczU2A/0, createdBy=56251941490, createdName=虈亣靌, createdTime=Thu Dec 22 13:24:48 CST 2016, time=2016-12-22, status=1, ipAttribution=)]
    2016-12-24 ailian1208
  6. [GetPortalCommentsPageByObjectIdResponse(id=1814749, encodeId=22ed1814e49e4, content=<a href='/topic/show?id=bd3d960016d' target=_blank style='color:#2F92EE;'>#重磅:2016年#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96001, encryptionId=bd3d960016d, topicName=重磅:2016年)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2b9b368, createdName=qingrejiedu, createdTime=Sun Sep 24 11:43:00 CST 2017, time=2017-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=165893, encodeId=272216589311, content=怎么看不到指南, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NdicLmdJEK9VoiaDianY6fzHNN9iaGv80m39pMHU3eSnNN0kn1o0rdQ7Bz2f03Qibcf1ia7rKvxIt4UVlErF2d4gCmDC5/0, createdBy=98e31740255, createdName=cqykthl, createdTime=Mon Dec 26 23:27:23 CST 2016, time=2016-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1319825, encodeId=ba5b1319825de, content=<a href='/topic/show?id=c806125e30b' target=_blank style='color:#2F92EE;'>#NCCN#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12573, encryptionId=c806125e30b, topicName=NCCN)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e572480, createdName=旅苦化文_208, createdTime=Sat Dec 24 02:43:00 CST 2016, time=2016-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1548972, encodeId=831415489e2c9, content=<a href='/topic/show?id=f7879600061' target=_blank style='color:#2F92EE;'>#重磅#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96000, encryptionId=f7879600061, topicName=重磅)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3acc14121561, createdName=xxxx1054, createdTime=Sat Dec 24 02:43:00 CST 2016, time=2016-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1602773, encodeId=ddec1602e73de, content=<a href='/topic/show?id=26141e6543f' target=_blank style='color:#2F92EE;'>#TOP30#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17654, encryptionId=26141e6543f, topicName=TOP30)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9b0318920751, createdName=ailian1208, createdTime=Sat Dec 24 02:43:00 CST 2016, time=2016-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=164915, encodeId=0b9316491533, content=可见知识更新的必要性, beContent=null, objectType=article, channel=null, level=null, likeNumber=120, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/11/19/9bc45f4ae162bd654210831f4e7ea3d0.jpg, createdBy=bbf11609910, createdName=杨帆7792, createdTime=Thu Dec 22 16:31:56 CST 2016, time=2016-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=164873, encodeId=306a1648e326, content=很好,不错的资料,值得收藏,给自己学习探究提供了方便。, beContent=null, objectType=article, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zMoyicyo6ia9f4IuLQAwZoxD6Hx4ibd5CMcOCYhStY6oDibbKK6O2X8iaicldO5ib8j1iapOIobIKCGiczU2A/0, createdBy=56251941490, createdName=虈亣靌, createdTime=Thu Dec 22 13:24:48 CST 2016, time=2016-12-22, status=1, ipAttribution=)]
    2016-12-22 杨帆7792

    可见知识更新的必要性

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=1814749, encodeId=22ed1814e49e4, content=<a href='/topic/show?id=bd3d960016d' target=_blank style='color:#2F92EE;'>#重磅:2016年#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=98, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96001, encryptionId=bd3d960016d, topicName=重磅:2016年)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2b9b368, createdName=qingrejiedu, createdTime=Sun Sep 24 11:43:00 CST 2017, time=2017-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=165893, encodeId=272216589311, content=怎么看不到指南, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mStl88fu4NdicLmdJEK9VoiaDianY6fzHNN9iaGv80m39pMHU3eSnNN0kn1o0rdQ7Bz2f03Qibcf1ia7rKvxIt4UVlErF2d4gCmDC5/0, createdBy=98e31740255, createdName=cqykthl, createdTime=Mon Dec 26 23:27:23 CST 2016, time=2016-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1319825, encodeId=ba5b1319825de, content=<a href='/topic/show?id=c806125e30b' target=_blank style='color:#2F92EE;'>#NCCN#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12573, encryptionId=c806125e30b, topicName=NCCN)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e572480, createdName=旅苦化文_208, createdTime=Sat Dec 24 02:43:00 CST 2016, time=2016-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1548972, encodeId=831415489e2c9, content=<a href='/topic/show?id=f7879600061' target=_blank style='color:#2F92EE;'>#重磅#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=97, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=96000, encryptionId=f7879600061, topicName=重磅)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3acc14121561, createdName=xxxx1054, createdTime=Sat Dec 24 02:43:00 CST 2016, time=2016-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1602773, encodeId=ddec1602e73de, content=<a href='/topic/show?id=26141e6543f' target=_blank style='color:#2F92EE;'>#TOP30#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17654, encryptionId=26141e6543f, topicName=TOP30)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9b0318920751, createdName=ailian1208, createdTime=Sat Dec 24 02:43:00 CST 2016, time=2016-12-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=164915, encodeId=0b9316491533, content=可见知识更新的必要性, beContent=null, objectType=article, channel=null, level=null, likeNumber=120, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/11/19/9bc45f4ae162bd654210831f4e7ea3d0.jpg, createdBy=bbf11609910, createdName=杨帆7792, createdTime=Thu Dec 22 16:31:56 CST 2016, time=2016-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=164873, encodeId=306a1648e326, content=很好,不错的资料,值得收藏,给自己学习探究提供了方便。, beContent=null, objectType=article, channel=null, level=null, likeNumber=121, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/mONcle9pic3zMoyicyo6ia9f4IuLQAwZoxD6Hx4ibd5CMcOCYhStY6oDibbKK6O2X8iaicldO5ib8j1iapOIobIKCGiczU2A/0, createdBy=56251941490, createdName=虈亣靌, createdTime=Thu Dec 22 13:24:48 CST 2016, time=2016-12-22, status=1, ipAttribution=)]
    2016-12-22 虈亣靌

    很好,不错的资料,值得收藏,给自己学习探究提供了方便。

    0

相关资讯

详解2016年FDA批准的20款创新药(名称、活性成分、适应症……)

导读 12月14日,FDA公布了2016年批准的第20个新分子药物Eucrisa,而后朋友圈被“CDER新药办公室主任John K. Jenkins博士的FDA新药审评情况”一文刷屏了。到目前为止FDA仅批准20个新分子药物,远低于去年的45个。本文详细解析了这20款创新药物的名称、活性成分、适应症……截止至2016年12月14日,FDA下属药品审评与研究中心(CDER)共批准了20个创新药:包括

盘点:2016年人工智能在医疗领域的发展

2016年,“人工智能”一词火了起来,啥是人工智能?人工智能是研究、开发用于模拟、延伸和扩展人的智能的理论、方法、技术及应用系统的一门新的技术科学;它是计算机科学的一个分支,企图了解智能的实质,并生产出一种新的能以人类智能相似的方式做出反应的智能机器,该领域的研究包括机器人、语言识别、图像识别、自然语言处理和专家系统等。1946年,第一台电子计算机ENIAC在美国诞生(另一说法是阿塔纳索夫•贝瑞计

2016年中国医疗电子市场产值将达74亿美元

相关研究机构预测,截至2016年,中国医疗电子市场产值将达到74亿美元,平均年复合率为13%。主要也是因为,全球对断层扫描仪、磁共振仪、高档超声波诊断仪器等产品的需求快速增长,带动了全球医疗电子市场规模的扩大。作为全球领先的高性能信号处理解决方案供应商,ADI公司一直致力于医疗电子产品开发与技术创新,并将继续保持其在医疗电子领域的优势,持续增加投入力度。ADI公司亚太区医疗行业市场经理王胜接受采访

Baidu
map
Baidu
map
Baidu
map